SCHEMBL25926535

SCHEMBL25926535

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5cccc6oc7cc(-n8c9ccccc9c9ccccc98)ccc7c56)cc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.36
CHEK2 O96017 1/20 0.34
PRKDC P78527 1/20 0.33
ALOX5 P09917 1/20 0.32
BACE1 P56817 1/20 0.32
HCRTR1 O43613 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PLA2G10 O15496 1/20 0.31
MMP12 P39900 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
AHR P35869 2/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
SIRT2 Q8IXJ6 1/20 0.30
SIRT1 Q96EB6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926631 1.00 PTGER4 (0.36) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL25926562 1.00 PTGER4 (0.36) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL24232675 0.98 PTGER4 (0.35) PTGER4CHEK2ALOX5BACE1HCRTR1
SCHEMBL25926563 0.97 BACE1 (0.33) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL24231956 0.97 PTGER4 (0.36) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL24264008 0.97 PTGER4 (0.34) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL25926684 0.97 PTGER4 (0.36) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL25926553 0.97 PTGER4 (0.34) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL25458753 0.96 PTGER4 (0.34) PTGER4CHEK2PRKDCALOX5BACE1
SCHEMBL25458795 0.96 PTGER4 (0.34) PTGER4CHEK2PRKDCALOX5BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 PTGER4 2825/4885CHEK2 1593/4885PRKDC 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.